Navigation Links
ev3 Inc. to Report 2008 Fourth Quarter and Full-Year Financial Results and Host Conference Call on February 24, 2009
Date:2/6/2009

PLYMOUTH, Minn., Feb. 6 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) will release its 2008 fourth quarter and full-year financial results and its financial guidance for 2009 on Tuesday, Febuary 24, 2009, before regular market trading hours.

The company will host a conference call and webcast the same day at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). ev3 management will review its fourth quarter and full-year operating results and future outlook, followed by a question and answer session.

The conference call will be available to interested parties through a live audio webcast at http://ir.ev3.net, where it will be archived and accessible for approximately 12 months. The live dial-in number for the call is 888-679-8034 (U.S.) or 617-213-4847 (International). The participant passcode is 49792760.

If you do not have access to the Internet and want to listen to an audio replay of the conference call, dial 888-286-8010 (U.S.) or 617-801-6888 (International) and enter passcode 62987548. The audio replay will be available beginning at 9:30 a.m. Central Time on Tuesday, February 24, 2009 until Tuesday, March 3, 2009.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of peripheral vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today - peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at www.ev3.net.

ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.


'/>"/>
SOURCE ev3 Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bioniche Reports Fiscal 2009 Second Quarter
2. GEN Reports on Strategies to Overcome Blood-Brain Barrier
3. Thoratec Reports 34 Percent Increase in 2008 Revenues
4. CardioDynamics Reports Eighth Consecutive Quarterly Revenue Increase Over Prior Year and 12% Revenue Growth in 2008
5. Cepheid Reports Fourth Quarter and Full Year 2008 Results
6. 80% of Caregivers Report Strain on Their Marriages
7. Masimo to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 3, 2009
8. Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008
9. Cardinal Health Reports Second Quarter Results
10. drugstore.com inc. Reports Profitable Fourth Quarter of 2008 and Free Cash Flow of $5.4 Million on Record OTC Sales
11. MedCath Corporation Reports First Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... , ... May 24, 2017 , ... ... Medical Center CEO Mary Ellen, hospital employees, and town officials to celebrate the ... The facility was developed by Rendina as part of its ongoing relationship with ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... innovative medical image management and interpretation, has received U.S. Food and Drug Administration ... Nucleus.io is a web-based, scalable and secure cloud platform for medical image management. ...
(Date:5/24/2017)... ... May 24, 2017 , ... STATEMENT OPPOSING PRESIDENT DONALD ... to Donald Trump’s budget, “A New Foundation for American Greatness—President's Budget FY 2018,” ... poor, marginalizes underserved populations, undermines productivity, and destroys the social safety net needed ...
(Date:5/24/2017)... Lehi, Utah (PRWEB) , ... May 24, 2017 , ... ... “Super Sick Kids: The Surprising Truth about Pediatric Septic Shock” hosted by the Journal ... 31, 2017, at 2 p.m. Eastern time, will be presented by Captain Rommie Duckworth, ...
(Date:5/24/2017)... ... ... Rob Lowe is a sought after actor, and also serves as the host ... topics from all aspects of life, and a new segment is being developed on ... , Podiatry is essential to people’s overall well-being, and if viewers have feet problems, ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... -- Fortuna Fix Inc. (" Fortuna "), a private, clinical-stage ... the need for embryonic and fetal stem cells by using ... Fortuna announced today the launch of its ... MD, PhD; Father Kevin FitzGerald , S.J., PhD; Col. ... James Giordano , PhD. "We are excited and ...
(Date:5/4/2017)... , May 4, 2017  A new ... thermoplastics and other highly-engineered materials, is being launched ... tubing has been developed in recent years to ... therapies and surgical applications. More expensive materials such ... produce microextrusion tubing due to their ability to ...
(Date:5/3/2017)... , May 3, 2017  West Pharmaceutical Services, ... solutions for injectable drug administration, announced today that ... and Technical Services, and Diane Paskiet , ... offering presentations focused on West,s expertise in the ... as well as providing commentary on updated industry ...
Breaking Medicine Technology: